Found: 6
Select item for more details and to access through your institution.
25-Hydroxyvitamin D variability within-person due to diurnal rhythm and illness: a case report.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152441
- By:
- Publication type:
- Article
Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0199265
- By:
- Publication type:
- Article
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.
- Published in:
- Nutrients, 2020, v. 12, n. 4, p. 988, doi. 10.3390/nu12040988
- By:
- Publication type:
- Article
Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180483
- By:
- Publication type:
- Article